Accessibility Menu
 
PharmaTher logo

PharmaTher

(OTC) PHRRF

Current Price$0.05
Market Cap$4.78M
Since IPO (2020)-71%
5 Year-74%
1 Year-64%
1 Month-12%

PharmaTher Financials at a Glance

Market Cap

$4.78M

Revenue (TTM)

$0.00

Net Income (TTM)

$1.47M

EPS (TTM)

$-0.01

P/E Ratio

-4.49

Dividend

$0.00

Beta (Volatility)

0.46 (Low)

Price

$0.05

Volume

107,936

Open

$0.05

Previous Close

$0.05

Daily Range

$0.05 - $0.05

52-Week Range

$0.05 - $0.55

PHRRF News

No articles available.

PHRRF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About PharmaTher

Industry

Pharmaceuticals

CEO

Fabio Chianelli

Headquarters

Toronto, ON M5C 1P1, CA

PHRRF Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-138%

Return on Capital

-3%

Return on Assets

-1%

Earnings Yield

-22.27%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.78M

Shares Outstanding

91.02M

Volume

107.94K

Short Interest

0.00%

Avg. Volume

151.56K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$1.52M

EBITDA

$1.52M

Operating Cash Flow

$1.21M

Capital Expenditure

$0.00

Free Cash Flow

$1.21M

Cash & ST Invst.

$1.12M

Total Debt

$0.00

PharmaTher Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$4.78M

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$248.17K

+32.5%

EBITDA

$244.07K

+29.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$769.80K

-50.4%

Accounts Receivable

$16.24K

-31.1%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.50%

N/A

Return on Invested Capital

-2.67%

N/A

Free Cash Flow

$233.09K

+29.7%

Operating Cash Flow

$233.09K

+29.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CHMMFChimeric Therapeutics Limited
$0.00+0.00%
BIXTBioxytran, Inc.
$0.04+8.72%
GLWLFGlow Lifetech Corp.
$0.04+8.50%
QNNTFQuantum Genomics S.A.
$0.10+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
UGROUrban-gro
$6.15+1.82%
TQQQProShares Trust - ProShares UltraPro Qqq
$44.57+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.95+0.07%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.58-0.03%

Questions About PHRRF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.